Whitehawk Therapeutics, Inc. Common Stock (WHWK)

• Market cap: $72.5M
• 1 day: -3.97%
• 5 days: -6.45%
• 1 month: -25.64%
• 3 months: -51.67%
• 6 months: -27.86%
• Year to date: -53.82%
• 1 year: -13.69%
• 5 years: 78.81%
• 10 years: -62.82%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 40

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

309% more call options, than puts

Call options by funds: $94K | Put options by funds: $23K

100% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 4 (+2) [Q4]

91% more capital invested

Capital invested by funds: $24.7M [Q3] → $47.2M (+$22.5M) [Q4]

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

2% more funds holding

Funds holding: 52 [Q3] → 53 (+1) [Q4]

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16